Steroids may be a daily necessity when you have CAH, and the side effects can be significant — here’s how to reduce their ...

ITV's Tonight programme has been told there are believed to be over one million performance-enhancing drug and anabolic ...

Treatment-resistant dermatomyositis improved significantly with the investigational TYK2/JAK1 inhibitor brepocitinib, according to a randomized trial. The higher of two doses of brepocitinib improved ...

Dr. Brittany Dulmage discusses how management of immune-related side effects can help patients stay on immunotherapy without compromising its effectiveness. As immunotherapy continues to transform ...

Posts with #TSW have had over a billion views on TikTok, sparking research into this mystery skin condition.

At 52 weeks, the 30-mg daily oral dose of brepocitinib outperformed the 15-mg dose in a study of patients with dermatomyositis resistant to previous treatments.

Dr. Brian S. Henick, a medical oncologist at Columbia University Irving Medical Center and director of the phase 1 program ...

Oral brepocitinib 30 mg was superior to placebo for treating dermatomyositis in adults already receiving standard therapies, according to phase 3 data presented at the American Academy of Dermatology ...

GoodRx reports on common mistakes in choosing allergy medications, highlighting the importance of proper options like steroid ...

Discover 9 important ibuprofen interactions to avoid. Learn which medications, supplements, foods, and alcohol can cause ...

The landscape of topical therapies for melasma is evolving quickly as a steady stream of new agents becomes available, offering alternatives to traditional frontline strategies, a dermatologist told ...

Wendy Smith Begolka, MBS, shares strategies to better meet the needs of patients with chronic inflammatory skin diseases.